Jagadish C. Sircar
Jagadish C. Sircar publishes mostly in Organic Chemistry, Molecular Biology and Physiology, on topics such as Biochemical and Molecular Research, Phenothiazines and Benzothiazines Synthesis and Activities and Synthesis and Reactions of Organic Compounds.
- World rank
- #3,247,551 of 7,710,434 ranked researchers
- Rank in United States
- #920,561 of 1,627,098
- Works
- 59
- Citations
- 1.3k
- Citations per work
- 22.7
What does Jagadish C. Sircar research?
Jagadish C. Sircar's work is mostly in Chemistry (35%), Biochemistry, Genetics and Molecular Biology (28%), Medicine (10%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Physical Sciences2034.6%
- Chemistry2034.6%
- Life Sciences2034.0%
- Everything else1321.6%
- Health Sciences69.8%
- Medicine69.8%
- 1Organic Chemistry35% of their works
- 2Molecular Biology22% of their works
- 3Physiology6% of their works
- 4Immunology6% of their works
- 5Epidemiology5% of their works
- 6Pharmacology5% of their works
Research topics
- Biochemical and Molecular Research
- Phenothiazines and Benzothiazines Synthesis and Activities
- Synthesis and Reactions of Organic Compounds
- Adenosine and Purinergic Signaling
- Cytomegalovirus and herpesvirus research
- Synthesis and Characterization of Heterocyclic Compounds
- Synthesis and Biological Evaluation
- Inflammatory mediators and NSAID effects
Which keywords describe Jagadish C. Sircar's research?
The keywords of their largest research topics: Synthesis, Anticancer, Antimicrobial, Catalyst, Heterocycles, Inflammation, Biological Evaluation and Enzyme Regulation.
- Quinoxaline
- Cyclooxygenase-2 Inhibitors
- Antimicrobial Activity
- Cytomegalovirus
- Adenosine Receptors
- Oxazolones
- Biological Activities
- Enzyme Regulation
- Inflammation
- Catalyst
- Anticancer
- Synthesis
- Antimicrobial
- Heterocycles
- Biological Evaluation
- Nucleotide Metabolism
- Imidazoles
- Phenothiazines
- Purinergic Signalling
- Infection
- Cancer
- Drug Discovery
- Triazines
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 23 words, with their numbers
- Synthesis344 topics
- Anticancer172 topics
- Antimicrobial172 topics
- Catalyst172 topics
- Heterocycles172 topics
- Inflammation162 topics
- Biological Evaluation142 topics
- Enzyme Regulation131 topic
- Nucleotide Metabolism131 topic
- Biological Activities101 topic
- Imidazoles101 topic
- Oxazolones101 topic
- Phenothiazines101 topic
- Adenosine Receptors91 topic
- Purinergic Signalling91 topic
- Cytomegalovirus81 topic
- Infection81 topic
- Antimicrobial Activity71 topic
- Cancer71 topic
- Cyclooxygenase-2 Inhibitors71 topic
- Drug Discovery71 topic
- Quinoxaline71 topic
- Triazines71 topic
Where does Jagadish C. Sircar work?
Jagadish C. Sircar's main affiliation in the publication record is Avanir Pharmaceuticals (United States), United States.
How many publications and citations does Jagadish C. Sircar have?
OpenAlex counts 59 works and 1,341 citations for Jagadish C. Sircar, an h-index of 22, ranking #3,247,551 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Jagadish C. Sircar. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.